Nur77 Inhibits Androgen-Induced Bladder Cancer Growth

REFERENCES

• Goebell PJ, Knowles MA. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Urol Oncol 2010;28:409–428.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Wu XR. Urothelial tumorigenesis: A tale of divergent pathways. Nat Rev Cancer 2005;5:713–725.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10–29.
   PubMed Web of Science ®Google Scholar
• Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 2009;115:68–74.
   PubMed Web of Science ®Google Scholar
• Hartge P, Harvey EB, Linehan WM, Silverman DT, Sullivan JW, Hoover RN, Fraumeni JF. Unexplained excess risk of bladder-cancer in men. J Natl Cancer Inst 1990;82:1636–1640.
   PubMed Web of Science ®Google Scholar
• Hemelt M, Yamamoto H, Cheng KK, Zeegers MPA. The effect of smoking on the male excess of bladder cancer: a meta-analysis and geographical analyses. Int J Cancer 2009;124:412–419.
   PubMed Web of Science ®Google Scholar
• Li Y, Izumi K, Miyamoto H. The role of the androgen receptor in the development and progression of bladder cancer. Jpn J Clin Oncol 2012;42:569–577.
   PubMed Web of Science ®Google Scholar
• Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 2007;99:558–568.
   PubMed Web of Science ®Google Scholar
• Johnson AM, O'Connell MJ, Miyamoto H, Huang J, Yao JL, Messing EM, Reeder JE. Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1. BMC Urol 2008;8:7–23.
   PubMedGoogle Scholar
• Boorjian SA, Heemers HV, Frank I, Farmer SA, Schmidt LJ, Sebo TJ, Tindall DJ. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder. Endocr Relat Cancer 2009;16:123–137.
   PubMed Web of Science ®Google Scholar
• Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh SY, Messing EM, Chang CS. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 2007;99:558–568.
   PubMed Web of Science ®Google Scholar
• Song CH, Gong EY, Park J, Lee K. Testicular steroidogenesis is locally regulated by androgen via suppression of nur77. Biochem Biophys Res Commun 2012;422:327–332.
   PubMed Web of Science ®Google Scholar
• Cho SD, Lee SO, Chintharlapalli S, Abdelrahim M, Khan S, Yoon K, Kamat AM, Safe S. Activation of nerve growth factor-induced b alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth. Mol Pharmacol 2010;77:396–404.
   PubMed Web of Science ®Google Scholar
• Zhan Y, Du X, Chen H, Liu J, Zhao B, Huang D, Li G, Xu Q, Zhang M, Weimer BC, Chen D, Cheng Z, Zhang L, Li Q, Li S, Zheng Z, Song S, Huang Y, Ye Z, Su W, Lin SC, Shen Y, Wu Q. Cytosporone b is an agonist for nuclear orphan receptor nur77. Nature Chem Biol 2008;4:548–556.
   PubMed Web of Science ®Google Scholar
• Parkin DM. The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl 2008:12–20.
   PubMedGoogle Scholar
• Wu JT, Han BM, Yu SQ, Wang HP, Xia SJ. Androgen receptor is a potential therapeutic target for bladder cancer. Urology 2010;75:820–827.
   PubMed Web of Science ®Google Scholar
• Taneja SS, Ha S, Swenson NK, Huang HY, Lee P, Melamed J, Shapiro E, Garabedian MJ, Logan SK. Cell-specific regulation of androgen receptor phosphorylation in vivo. J Biol Chem 2005;280:40916–40924.
   PubMed Web of Science ®Google Scholar
• Wilson CM, McPhaul MJ. A and b forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol 1996;120:51–57.
   PubMed Web of Science ®Google Scholar
• Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS. Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology 2004;64:383–388.
   PubMed Web of Science ®Google Scholar
• Johnston L, Carson C, Lyons AD, Davidson RA, McCloskey KD. Cholinergic-induced Ca2+ signaling in interstitial cells of cajal from the guinea pig bladder. Am J Physiol Renal Physiol 2008;294:F645–F655.
   PubMed Web of Science ®Google Scholar
• Maxwell MA, Muscat GE. The nr4a subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal 2006;4:e002–e009.
   PubMedGoogle Scholar
• Myers SA, Eriksson N, Burow R, Wang SC, Muscat GE. Beta-adrenergic signaling regulates nr4a nuclear receptor and metabolic gene expression in multiple tissues. Mol Cell Endocrinol 2009;309:101–108.
   PubMed Web of Science ®Google Scholar
• Zhu X, Walton RG, Tian L, Luo N, Ho SR, Fu Y, Garvey WT. Prostaglandin A2 enhances cellular insulin sensitivity via a mechanism that involves the orphan nuclear receptor NR4A3. Horm Metab Res 2013;45:213–220.
   PubMed Web of Science ®Google Scholar
• McMorrow JP, Murphy EP. Inflammation: a role for nr4a orphan nuclear receptors? Biochem Soc Trans 2011;39:688–693.
   PubMed Web of Science ®Google Scholar
• Pei L, Waki H, Vaitheesvaran B, Wilpitz DC, Kurland IJ, Tontonoz P. Nr4a orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 2006;12:1048–1055.
   PubMed Web of Science ®Google Scholar
• Arkenbout EK, de Waard V, van Bragt M, van Achterberg TA, Grimbergen JM, Pichon B, Pannekoek H, de Vries CJ. Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 2002;106:1530–1535.
   PubMed Web of Science ®Google Scholar